SOURCE: Targeted Genetics

May 08, 2008 07:30 ET

Targeted Genetics to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference

SEATTLE, WA--(Marketwire - May 8, 2008) - Targeted Genetics Corporation (NASDAQ: TGEN) announced today that H. Stewart Parker, President and Chief Executive Officer, will present a company overview at the Rodman & Renshaw 5th Annual Global Healthcare Conference on Monday, May 19 at 9:20 a.m., Monte Carlo, Monaco.

The presentation will be webcast live and available for replay from the Targeted Genetics website, A link to connect to the webcast will be under the "Events" section of the Company's homepage.

About Targeted Genetics

Targeted Genetics Corporation is a biotechnology company committed to the development of innovative targeted molecular therapies for the prevention and treatment of acquired and inherited diseases with significant unmet medical need. Targeted Genetics' proprietary Adeno-Associated Virus (AAV) technology platform allows it to deliver genes that encode proteins to increase gene function or RNAi to decrease or silence gene function. Targeted Genetics' product development efforts target inflammatory arthritis, AIDS prophylaxis, congestive heart failure and Huntington's disease. To learn more about Targeted Genetics, visit Targeted Genetics' website at

Contact Information

  • Investor and Media Contact:
    Stacie D. Byars
    WeissComm Partners
    Email Contact

    Carolyn Wang
    WeissComm Partners
    Email Contact